Researchers Provide Update On Two Participants In Pilot Trial Of Cyberkinetics Inc.'s BrainGate(TM) System

FOXBOROUGH, Mass.--(BUSINESS WIRE)--Nov. 14, 2005--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) (Cyberkinetics) reports its latest findings with respect to the Company’s BrainGate(TM) Neural Interface System in two posters today at the Annual Meeting of the Society for Neuroscience in Washington, D.C. The poster presentations include detailed discussions of the scientific, mathematical and practical observations related to the first of two participants, each with quadriplegia, using their own thoughts and the BrainGate(TM) System (BrainGate) to control a computer in an ongoing pilot study of the system. Progress toward the development of automated software to support the BrainGate System will also be reported. The detailed information includes positive initial observations from the second participant in the BrainGate pilot trial.

MORE ON THIS TOPIC